# New Study Shows Positive Impact of Tirzepatide and Semaglutide on Adults Living with Obesity and Type 2 Diabetes ## Key Points: – The Lancet published a study demonstrating the impact of tirzepatide and semaglutide on adults with obesity and type 2 diabetes. – The study, based on real-world evidence from an international retrospective cohort, highlights the incidence of new onset type 2 diabetes in these individuals. – Tirzepatide and semaglutide treatment has shown promising results in managing diabetes and obesity in adults based on the data collected. – This study sheds light on the effectiveness of these medications in real-world settings, providing valuable insights for healthcare providers and patients alike. ### Strong Efficacy of Tirzepatide and Semaglutide Reinforces Their Role in Diabetes and Obesity Management The findings from this international retrospective cohort study published in The Lancet emphasize the positive impact of tirzepatide and semaglutide in managing type 2 diabetes in adults living with obesity. The real-world evidence presented in the study underscores the importance of these medications in effectively addressing the dual challenges of diabetes and obesity. Healthcare providers can leverage these insights to optimize treatment strategies for their patients, leading to better health outcomes. Contact Mindful Evolution today to learn more about how telehealth services can support your weight loss journey in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia. **Weight Loss Disclaimer: This article is for informational purposes only and does not constitute medical advice. Please consult a healthcare professional for personalized recommendations.**